Skip to content

TranshumanismAustralia Join · 14 days free

The Transhuman Daily · EP.001 · Monday 2 November 2026

NEVER TOO LATE.

Never too late: two treatments helped old mice live longer, retiring didn't make older Australians lonelier, and a psychedelic spray eased tough depression in a mid-stage trial.

Download (56.3 MB)

The Transhuman Daily

NEVER TOO LATE

Blocking one enzyme helped old mice live 17% longer
Chinese researchers put the AEP blocker #11a in the food of 18-month-old mice, which then lived 28 months on average against 24 untreated (17% longer) and did better on memory, strength and exercise tests. A hint that blocking AEP may ease signs of ageing, but it's a small mouse study, not tested in people.
Super longevity Mouse study, small groups · IN MICE · iScience, ScienceAlert
Retiring didn't make older Australians any lonelier
A Monash-led study of 7,434 Australians aged 55 to 75, followed for nearly two decades, found no 'loneliness cliff' at retirement: loneliness didn't change in the three years before or after. In this observational data, loneliness tends to rise from the late 60s, with age rather than leaving work.
Super wellbeing Observational study, 7,434 Australians · Monash University (Mirage News), Scientific Reports

The Transhuman Daily

SUPER INTELLIGENCE

An AI agent reading abdominal ultrasounds got 99.6% of diagnoses right in 100 checked reports
CU Anschutz's vision-language AI agent reads abdominal ultrasounds and drafts reports for radiologists to check, as a helper rather than a replacement; in 100 reports researchers reviewed, it got the diagnoses right 99.6% of the time. A research study across about 11,000 scans, not yet tested in real-world emergency care.
Super intelligence Peer-reviewed study, ~11,000 scans · THIS WEEK · Nature Communications, CU Anschutz (Mirage News)
Elon Musk says Neuralink's Blindsight implant is ready and waiting on regulators
Elon Musk says Neuralink's Blindsight implant, aimed at blindness, is 'ready from an engineering standpoint' and 'just waiting on regulatory approval'. It's a company claim: Blindsight has had FDA Breakthrough Device designation since September 2024, but no regulator has cleared it.
Super intelligence Company claim · COMPANY CLAIM · TeslaNorth
A five-year Miami study aims to make brain implants last longer
Brain implants for BCIs, Parkinson's and paralysis trigger inflammation and scarring that wear them down over time. University of Miami researchers are starting a five-year, NIH-supported study of IC 100, an antibody that prevented some implant inflammation in earlier animal trials, to help implants last longer.
Super intelligence Study launch; animal data so far · THIS WEEK · University of Miami (Mirage News)
50 AI agents told to build a Minecraft civilization built a bureaucracy instead
Y Combinator and Olam Labs gave 50 AI agents three hours to build a thriving Minecraft civilization; it never thrived, and four agents spent 11 minutes appointing a 'sole fertilizer operator'. A playful lesson in how AI teams coordinate, from an informal test on the researchers' blog, not a peer-reviewed study.
Super intelligence Informal test, not peer reviewed · Tom's Hardware, Mezha

The Transhuman Daily

SUPER LONGEVITY

A vaccine against worn-out 'zombie' cells helped old mice live 12% longer
A senolytic nanovaccine trains the immune system to clear worn-out 'zombie' cells; old mice vaccinated at 75 weeks lived 12% longer (median) and had better glucose control. A proof of concept for healthier ageing, only in mice, with 10 per group and short-lived controls, so it needs repeating.
Super longevity Mouse study, 10 mice per group · IN MICE · Lifespan.io, Advanced Science
UK clears gene-editing treatment Casgevy for children from age five
Britain's MHRA extended Casgevy, which edits a faulty gene in a patient's own bone marrow stem cells so the body makes working haemoglobin, to children aged five and over with severe sickle cell disease or transfusion-dependent beta-thalassaemia. It was previously approved for ages 12 and up.
Super longevity Approved by the UK MHRA · THIS WEEK · MHRA (GOV.UK), Mirage News
Older adults who napped most days had a 48% higher dementia rate
A Johns Hopkins-led study followed 995 Americans aged 65 and over for a median of five years: those who napped every day or most days had a 48% higher rate of dementia. It shows a link, not a cause; frequent napping may be an early sign of brain changes.
Super longevity Observational study, 995 older adults · ScienceAlert, The Journals of Gerontology: Series A
The Dog Aging Project won US$29 million to learn why some dogs age better
The US NIH is giving the Dog Aging Project about US$29 million over five more years to study the genes, environments and lifestyles of its nearly 55,000 pet dogs, to learn why some age better, which could point to ways to intervene. It's funding for an observational study, not a result.
Super longevity Funding for an observational study · THIS WEEK · Longevity.Technology, Texas A&M

The Transhuman Daily

SUPER WELLBEING

One dose of a psychedelic nasal spray eased hard-to-treat depression for 8 weeks in a trial
In a phase 2b trial of 193 adults with hard-to-treat depression, including at sites in Australia, one dose of 5-MeO-DMT nasal spray with psychological support eased symptoms for at least eight weeks compared with a very low dose (JAMA). Company-funded and mid-stage; the 8 mg dose now moves to phase 3.
Super wellbeing Phase 2b trial, 193 people · THIS WEEK · JAMA, ScienceAlert
18 and Up, Australia's biggest study of wellbeing and ageing, starts recruiting 100,000 people
The Sax Institute's 18 and Up will follow 100,000 Australians aged 18 to 90+ through their lives, to understand rising mental illness in young people and early-onset cancer. Recruitment starts in November with a $4.5m NHMRC grant: a study launch, not results yet.
Super wellbeing Study launch · THIS WEEK · The Guardian

The Transhuman Daily

THE CATCH

An Alzheimer's antibody lowered plaque but didn't slow decline
Acumen's antibody sabirnetug significantly reduced amyloid plaque in a phase 2 trial of 542 people with early Alzheimer's, but didn't slow decline versus placebo at 18 months, so the company has stopped developing it. Topline results from the company; full data to come.
Super longevity Phase 2 trial, 542 people · THIS WEEK · Acumen Pharmaceuticals (GlobeNewswire), RTTNews
AI translation sounds fluent but isn't always right: one turned Aussie thongs into underwear
Writing in The Conversation, a translation researcher shows how fluent AI translations can hide errors: one turned a student's line about Australian professors wearing thongs (flip-flops) to class into G-strings. Fluency doesn't equal accuracy, and it can't be guaranteed.
Super intelligence Expert commentary · The Conversation

The Transhuman Daily

THE FRONTIER

SpaceX flew Falcon 9 for the 700th time and landed the booster at sea
Falcon 9 flew for the 700th time, carrying 27 Starlink satellites from Vandenberg on 30 October (California time), and booster B1093 landed on a droneship on its 18th flight, a milestone for reusable rockets. SpaceX is now winding Falcon down as it turns to Starship.
Frontier tech Launch milestone · THIS WEEK · Spaceflight Now, TeslaNorth
Google's AI satellite Suncatcher wrote a haiku from orbit
Google's Suncatcher prototype, a data-centre satellite with four TPUs launched on a Falcon 9, is online, and its first prompt asked the Gemma 4 model on board for a haiku: 'Blue marble below / Data streams in silent grace / Starlight feeds my core'. Next it tests AI chips under heat and radiation, with two more satellites planned for 2027.
Frontier tech Company announcement (prototype) · THIS WEEK · TechCrunch, The Verge
A humanoid robot traffic cop helped patrol the Hangzhou Marathon
Hangxing No.2, a 178 cm DEEP Robotics humanoid, joined the traffic patrol at the 2026 Hangzhou Marathon (36,000 runners), monitoring intersections and warning of violations. Humanoid traffic robots have been tested in Hangzhou since May 2026; this account is from state media.
Frontier tech State-media report · Global Times

Transcript

Read the narration

This is the Transhuman Daily, for Monday, November 2.

Here are the last 24 hours in transhumanism, in 3 minutes.

The week's best? It's never too late.

Old mice given an enzyme blocker lived 17% longer.

Closer to home, Monash found retiring didn't make older Australians any lonelier.

In AI, an agent reading abdominal ultrasounds got the diagnosis right 99.6% of the time.

Elon Musk says Neuralink's Blindsight, an implant aimed at blindness, is ready. Regulators still have to agree.

Trouble is, implants fade as the brain scars around them.

A five-year Miami study wants them to last.

And 50 AI agents, told to build a Minecraft civilization, built a bureaucracy instead.

In the longevity lab, a vaccine against worn-out 'zombie' cells helped old mice live 12% longer.

And Britain cleared Casgevy, a gene-editing treatment for two inherited blood disorders, for kids from age 5.

Seniors who napped most days had a 48% higher dementia rate.

Maybe a sign, not a cause.

Plus, the Dog Aging Project won US$29 million to learn why some dogs age better.

In a mid-stage trial, one dose of a psychedelic nasal spray eased hard-to-treat depression for 8 weeks.

And Australia's biggest study of wellbeing and ageing acro ss generations starts recruiting 100,000 people this month.

Now, the catch. An Alzheimer's drug lowered plaque but didn't slow decline, in a trial of over 500 people.

And AI translation sounds fluent, but isn't always right.

One turned Aussie thongs into underwear.

Meanwhile, SpaceX flew Falcon 9 for the 700th time, and the booster landed at sea again.

One recent passenger, Google's AI satellite, just wrote a haiku from orbit.

In Hangzhou, a humanoid robot traffic cop helped patrol a marathon of 36,000 runners.

Old mice, old dogs, new tricks.

It's never too late to start something new. Even a daily show.

Day after day, the curve keeps bending upward.

Somehow, the future keeps landing early.

That's one day of news. Imagine what a year looks like.

This has been the Transhuman Daily.

Stay well. Same time tomorrow?

Want more? Meet us in North Sydney on November 27.

Good to know

Window: the week's best, mostly the 72 hours to 14:00 AEDT, Mon 2 Nov 2026; items older than about 30 hours (back to Tue 27 Oct) are marked THIS WEEK. This week: the nasal-spray trial (JAMA, 27 Oct), Neuralink's Blindsight claim (29 Oct), 18 and Up (29 Oct) and the ultrasound AI (announced 29-30 Oct; the paper appeared on 7 Sept). Evidence: both lifespan results are in mice, in small groups; the napping link is observational; Blindsight being 'ready' is Elon Musk's claim; Acumen's results are topline. Screenshots are the publishers' public pages as captured on 2 Nov 2026; copyright remains with the publishers. Every headline links to its source. The narrator is an AI voice; the visuals and music are generated for each episode. Nothing here is medical or financial advice.

Membership

Join the movement

Membership is how the movement grows. It keeps our meetups free and open to everyone, and it puts you in the room with the people building a longer, healthier, smarter future.

Keep the meetups free Your support keeps every monthly meetup free and open, and brings great speakers to Sydney.
Member deep-dives Guided tutorials and deep-dives on AI, longevity, neurotech and more, so you learn by doing.
Meet the builders Founders, researchers, investors and biohackers working on transhuman technology.
Hear it first New events, projects and opportunities across our network, before anyone else.

Not ready yet? Come to a free meetup first.

Join · 14 days free RSVP 27 Nov